|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2010-9-24
|
|
pubmed:abstractText |
The purpose of this study was to investigate the effects of varespladib on cardiovascular biomarkers in acute coronary syndrome patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Indoles,
http://linkedlifedata.com/resource/pubmed/chemical/Phospholipases A2, Secretory,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles,
http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin,
http://linkedlifedata.com/resource/pubmed/chemical/varespladib
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1558-3597
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
28
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1079-88
|
|
pubmed:dateRevised |
2011-5-10
|
|
pubmed:meshHeading |
pubmed-meshheading:20863951-Acetic Acids,
pubmed-meshheading:20863951-Acute Coronary Syndrome,
pubmed-meshheading:20863951-Aged,
pubmed-meshheading:20863951-Biological Markers,
pubmed-meshheading:20863951-C-Reactive Protein,
pubmed-meshheading:20863951-Cholesterol, LDL,
pubmed-meshheading:20863951-Dose-Response Relationship, Drug,
pubmed-meshheading:20863951-Double-Blind Method,
pubmed-meshheading:20863951-Drug Administration Schedule,
pubmed-meshheading:20863951-Drug Therapy, Combination,
pubmed-meshheading:20863951-Female,
pubmed-meshheading:20863951-Follow-Up Studies,
pubmed-meshheading:20863951-Heptanoic Acids,
pubmed-meshheading:20863951-Humans,
pubmed-meshheading:20863951-Indoles,
pubmed-meshheading:20863951-Logistic Models,
pubmed-meshheading:20863951-Male,
pubmed-meshheading:20863951-Middle Aged,
pubmed-meshheading:20863951-Phospholipases A2, Secretory,
pubmed-meshheading:20863951-Prospective Studies,
pubmed-meshheading:20863951-Pyrroles,
pubmed-meshheading:20863951-Reference Values,
pubmed-meshheading:20863951-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients.
|
|
pubmed:affiliation |
Mount Sinai School of Medicine, New York, New York 10029, USA. robert.rosenson@mssm.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Clinical Trial, Phase II
|
